A carregar...
Emerging drugs for myelofibrosis
INTRODUCTION: Myelofibrosis (MF), a Philadelphia chromosome-negative myeloproliferative neoplasm, is a life-threatening heterogeneous disorder characterized by dysregulation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling network. The clinical hallmarks of...
Na minha lista:
| Publicado no: | Expert Opin Emerg Drugs |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5009610/ https://ncbi.nlm.nih.gov/pubmed/23186315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728214.2012.748748 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|